Related Experiment Video
Updated: Jun 10, 2026
05:36
Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
Cardioprotection in the clinical setting-lessons from J-WIND studies
Masanori Asakura1, Masafumi Kitakaze
1Department of Clinical Research, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, 565-8565, Japan. asamasa@xd5.so-net.ne.jp
Cardiovascular Drugs and Therapy
|August 7, 2010
Summary
Current treatments for ischemic heart disease focus on prevention and managing complications. However, there
Area of Science:
- Cardiovascular Medicine
- Ischemic Heart Disease Research
Background:
- Ischemic heart disease management involves preventing initial events and mitigating damage.
- Strategies include addressing causes, reducing ischemic/reperfusion injury, and preventing heart failure progression.
Purpose of the Study:
- To explore potential cardioprotective mechanisms for acute myocardial infarction.
- To identify adjunctive therapies for reducing infarct size during the acute phase.
Main Methods:
- Review of existing treatment strategies for ischemic heart disease.
- Analysis of recent clinical trial data (e.g., J-WIND trials) on novel therapeutic approaches.
Main Results:
- Established treatments like aspirin and statins are used for acute myocardial infarction prevention.
- Medications such as ACE inhibitors, beta-blockers, and ARBs are used for post-infarction heart failure.
- No current adjunctive therapy effectively reduces infarct size in the acute phase.
Conclusions:
- Human atrial natriuretic peptide and nicorandil show promise in improving outcomes post-myocardial infarction.
- Further research into cardioprotective mechanisms is needed to develop new acute-phase therapies.
Related Concept Videos
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:21Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...